Neoadj T-VEC May Improve Survival in Resectable Melanoma

Offering talimogene laherparepvec before surgery compared with surgery alone could improve event-free as well as overall survival in patients with advanced resectable melanoma, a new analysis suggests.
Medscape Medical News

source https://www.medscape.com/viewarticle/neoadjuvant-t-vec-may-improve-survival-resectable-melanoma-2023a1000ji5?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?